-
Public trust in use of Big Data for health science ‘is vital’: researchers
europeanpharmaceuticalreview
April 22, 2019
Maintaining public confidence in the use of Big Data for health research is essential, according to international researchers.
-
Sangamo, Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy
americanpharmaceuticalreview
April 11, 2019
Sangamo, Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy.
-
U.K. sets out digital, data-driven plan to accelerate R&D
fiercebiotech
January 02, 2019
The U.K. government has set out how it plans to use data and digital technologies to attract clinical trials. Near-term plans include the creation of a system for assessing study feasibility and an app to connect patients to studies.....
-
NHS risks losing revenue without data strategy
pharmatimes
December 11, 2018
Think tank Reform has warned that the National Health Service risks losing out on huge potential revenue in the future if it does not put in place a strategy to capitalise on the increasing value of its medical data.
-
Data show Imnovid-based triple therapy PFS benefit in blood cancer
pharmatimes
July 06, 2018
Celgene has presented Phase III data showing a significant progression-free survival (PFS) benefit in patients with multiple myeloma taking a triple combination therapy of Imnovid, Velcade and low-dose dexamethasone.
-
Data show ‘enduring’ benefits of GSK’s Nucala
pharmatimes
May 24, 2018
According to results of the COLUMBA trial, which GSK says is the longest study of an anti-IL5 biologic treatment in severe eosinophilic asthma to be reported
-
Why Choose a Site Network for Your Clinical Trials?
fiercebiotech
May 08, 2018
With an established operational management system, the site network optimizes daily flow in the clinics, especially given that the flow is dedicated solely to research-related activities.
-
Merck to co-lead Big Data alliance
pharmatimes
September 12, 2017
Merck will join forces with Project Data Sphere – an independent, not-for-profit initiative of the CEO Roundtable on Cancer's Life Sciences Consortium – to jointly lead the Global Oncology Big Data Alliance (GOBDA).
-
Lilly to Present Data for Galcanezumab for the Prevention of Migraine at the American Academy of Neu
lilly
April 21, 2017
Eli Lilly and Company (NYSE: LLY) will highlight Phase 2 data evaluating galcanezumab for the prevention of migraine at the American Academy of Neurology (AAN) annual meeting, which will take place April 22-28, 2017, in Boston.
-
Research paper slams DeepMind/Royal Free NHS Trusts data deal
pharmatimes
March 20, 2017
A controversial deal between Google’s artificial intelligence unit DeepMind and The Royal Free London NHS Foundation...